Ellen de Bock

University Medical Center Utrecht

Papers

1

Total Citations

44

H-Index

1

About

Dr. Ellen de Bock is a leading surgical oncologist whose research focuses on advancing breast cancer treatment through minimally invasive techniques. Her major contributions center on evaluating the safety and efficacy of robotic nipple-sparing mastectomy (R-NSM) compared to traditional approaches. In her landmark 2021 systematic review and meta-analysis, which has garnered 44 citations, Dr. de Bock demonstrated that R-NSM offers comparable complication rates to conventional NSM, providing crucial evidence for the adoption of robotic-assisted surgery in breast oncology. This work addresses a critical need in breast cancer care, as NSM is widely used for both therapeutic and prophylactic mastectomies. By systematically analyzing complication data, she has helped establish benchmarks for surgical outcomes, directly impacting clinical decision-making for patients and surgeons. Her research is particularly significant given breast cancer’s status as the most common cancer in women worldwide. Dr. de Bock’s contributions have positioned her as a key voice in the ongoing evolution of breast surgery, bridging the gap between technological innovation and patient safety. Her work continues to inform best practices in oncologic surgery, making her a respected authority in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
44
Total Citations
44
Avg Citations/Paper
🏆 Most Cited Paper
Robotic nipple-sparing mastectomy complication rate compared to traditional nipple-sparing mastectomy: a systematic review and meta-analysis
44 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University Medical Center Utrecht

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago